{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:22:45Z","timestamp":1791926565758,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.bone.2004.03.008","type":"journal-article","created":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T15:51:08Z","timestamp":1087833068000},"page":"231-234","source":"Crossref","is-referenced-by-count":61,"title":["Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta"],"prefix":"10.1016","volume":"35","author":[{"given":"Craig F","family":"Munns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.03.008_BIB1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astrom","year":"2002","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bone.2004.03.008_BIB2","series-title":"Connective Tissue and Its Heritable Disorders","first-page":"385","article-title":"Osteogenesis imperfecta","author":"Byers","year":"2002"},{"key":"10.1016\/j.bone.2004.03.008_BIB3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s004310000505","article-title":"Osteogenesis imperfecta: profiles of motor development as assessed by a postal questionnaire","volume":"159","author":"Engelbert","year":"2000","journal-title":"Eur. J. Pediatr."},{"issue":"Suppl. 6","key":"10.1016\/j.bone.2004.03.008_BIB4","first-page":"1491","article-title":"The use of bisphosphonates in children with osteogenesis imperfecta","volume":"14","author":"Glorieux","year":"2001","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.03.008_BIB5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2004.03.008_BIB6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S8756-3282(96)00224-4","article-title":"Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study","volume":"19","author":"Gutteridge","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.008_BIB7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcn\/32.3.607","article-title":"Physical growth: National Center for Health Statistics percentiles","volume":"32","author":"Hamill","year":"1979","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2004.03.008_BIB8","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1542\/peds.111.5.e601","article-title":"Rapid increase in grip force after start of pamidronate therapy in children and adolescents and severe osteogenesis imperfecta","volume":"111","author":"Montpetit","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2004.03.008_BIB9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2000.15.1.147","article-title":"Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations","volume":"15","author":"Pecherstorfer","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.008_BIB10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.85.5.1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.03.008_BIB11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","article-title":"Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism","volume":"88","author":"Rauch","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.03.008_BIB12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.008_BIB13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0140-6736(94)91267-X","article-title":"Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma","volume":"343","author":"Rolla","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2004.03.008_BIB14","first-page":"216","article-title":"Mortality in various types of osteogenesis imperfecta","volume":"33","author":"Singer","year":"2001","journal-title":"J. Insur. Med."},{"key":"10.1016\/j.bone.2004.03.008_BIB15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Thiebaud","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.03.008_BIB16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/JPEM.2002.15.2.163","article-title":"Pamidronate treatment of osteogenesis imperfecta\u2014Lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response","volume":"15","author":"Zacharin","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.03.008_BIB17","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during long-term therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T15:52:55Z","timestamp":1549468375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S8756328204001139"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.03.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}